Catalyst Wire Dossier Catalyst Wire Dossier

Hetrombopag Olamine

Hetrombopag · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Hetrombopag Olamine, covering 2015-04-06 to 2022-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient [Phase 3]

See pricing